No Data
TMCI Stock May Gain From the Limited Release of the Percuplasty System
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference
Sector Update: Health Care Stocks Mixed Late Afternoon
This Vertex Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Tuesday
Lake Street Initiates Treace Medical Concepts(TMCI.US) With Buy Rating, Announces Target Price $14.5
Treace Expands Reach Into High-Volume Osteotomy Market With Second MIS Osteotomy Platform, Percuplasty Percutaneous 3D Bunion Correction Procedure
(SHORT) then when you FEEL it's a spike back up for a BULL 
Cover (Sell) your SHORT then renter for a BULL 
and SEEING EVERYTHING not one way.
